Oncimmune Holdings ( (GB:ONC) ) just unveiled an update.
Oncimmune Holdings PLC has announced a change in the voting rights held by Balderton Capital III, LP, which now holds 5.87% of the voting rights in the company, down from a previous 6.09%. This adjustment in holdings may impact the company’s shareholder dynamics and influence its strategic decisions moving forward.
More about Oncimmune Holdings
Oncimmune Holdings PLC is a UK-based company operating in the healthcare industry, specializing in the development and commercialization of immunodiagnostic tests for the early detection of diseases, particularly cancer.
YTD Price Performance: -92.06%
Average Trading Volume: 416,938
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.27M
Find detailed analytics on ONC stock on TipRanks’ Stock Analysis page.